Ultacan

Active Ingredient(s): Articaine Hydrochloride + Epinephrine
FDA Approved: * July 11, 2017
Pharm Company: * HANSAMED INC
Category: Anesthetic

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Ultacan Overview

Articaine is a dental amide-type local anesthetic. It is the most widely used local anesthetic in a number of European countries[2] and is available in many countries. It is the only local anaesthetic to contain a thiophene ring, meaning it can be described as 'thiophenic'; this conveys lipid solubility.[3] Contents 1 History 2 Structure and metabolism 3 Clinical use 4 Contraindications 5 Paresthesia controversy 6 References 7 External links History This...

Read more Ultacan Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Articaine

Recent Ultacan Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Articaine Hydrochloride + Epinephrine
  • Injection: 4% + 0.0085mg/1.7ml (4% + 0.005mg/ml), 4% + 0.0085mg/1.7ml(4% + 0.005mg/ml), 4% + 0.017mg/1.7ml (4% + 0.01mg/ml), 4% + 1:200000, 4;1:100,000% + 4;1:100,000%, 4;1:100000% + 4;1:100000%
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Ultacan: (1 result)

Sorted by National Drug Code
  • 52120-200 Ultacan Submucosal Injection, Solution by Hansamed, Inc.

Drugs with one or more similar ingredients: (42 results)